When should CADASIL be considered in a middle‑aged adult with white‑matter hyperintensities on MRI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Consider CADASIL in Middle-Aged Adults with White Matter Hyperintensities on MRI

CADASIL should be strongly suspected when MRI shows white matter hyperintensities with characteristic involvement of the anterior temporal poles and/or external capsules, particularly in patients under 60 years presenting with recurrent subcortical strokes, migraine with aura, mood disorders, or cognitive decline—especially when accompanied by a family history of similar symptoms or early stroke/dementia. 1

Key Imaging Features That Should Trigger CADASIL Consideration

The most diagnostically valuable MRI findings include:

  • Anterior temporal pole involvement: This is the most specific imaging marker, present in 95% of high-risk NOTCH3 variant carriers and 54% of medium-risk carriers 2. The sensitivity for distinguishing CADASIL from sporadic small vessel disease is 95% when temporal pole lesions are present 2

  • External capsule white matter hyperintensities: Multiple lesions affecting the external capsule alongside temporal involvement create a highly suggestive pattern 1, 3

  • Symmetric, confluent subcortical white matter changes: Unlike typical age-related changes or sporadic small vessel disease, CADASIL produces extensive symmetric white matter abnormalities 1

  • Lacunar infarcts in basal ganglia and thalamus: These accompany the white matter changes and help distinguish CADASIL from inflammatory conditions 4

Critical distinction: In sporadic small vessel disease, temporal pole involvement occurs in only 32% of patients, making this location particularly discriminating 2.

Clinical Red Flags Beyond Imaging

Consider CADASIL when you encounter:

Age and Presentation Pattern

  • Symptom onset typically at age 45 years (range 30-50), with migraine with aura appearing earlier (mean age 38) than ischemic events (mean age 49) 5
  • Recurrent subcortical ischemic events (84% of affected individuals) without traditional vascular risk factors 5, 6
  • MRI abnormalities are always present by age 35 in mutation carriers, even when asymptomatic 4

Clinical Syndrome Components

  • Migraine with aura (22% of patients) occurring years before stroke symptoms 5
  • Mood disorders with severe depressive episodes (20%) or prominent apathy 5, 7
  • Progressive subcortical dementia with pseudobulbar palsy (31%) 5
  • Cognitive decline affecting executive function more prominently than memory initially 8

Family History

  • Autosomal dominant pattern with stroke, dementia, or psychiatric illness in multiple generations
  • Family members dying in their 40s-60s from progressive neurological disease 6
  • Penetrance is complete by age 30-40 years based on MRI findings 5

Common Diagnostic Pitfalls to Avoid

  1. Don't dismiss CADASIL due to presence of vascular risk factors: While classically described as occurring without traditional risk factors, patients may have coexisting hypertension or other conditions 9. The imaging pattern and age of onset remain key.

  2. Don't confuse with multiple sclerosis: MS lesions are typically ovoid, perpendicular to ventricles ("Dawson's fingers"), and spare the anterior temporal poles. CADASIL shows confluent symmetric changes with temporal involvement 1, 6

  3. Beware of variant-dependent sensitivity: The diagnostic accuracy of temporal pole lesions varies by NOTCH3 mutation type—high-risk variants show 95% sensitivity, but medium-risk (54%) and low-risk (33%) variants are less reliable, particularly in Asian populations where medium-risk founder variants are prevalent 2

  4. Don't overlook atypical presentations: Some patients present with normal pressure hydrocephalus-like syndrome (gait disturbance, incontinence, cognitive decline) with ventriculomegaly, but the presence of temporal pole and external capsule hyperintensities should redirect diagnosis 10

Diagnostic Workup Algorithm

When CADASIL is suspected:

  1. Obtain comprehensive MRI sequences including T2-FLAIR, T2-weighted, susceptibility-weighted imaging (SWI) or gradient echo (GRE), and T1-weighted sequences 11

  2. Systematically assess for:

    • Anterior temporal pole hyperintensities (most specific)
    • External capsule involvement
    • Symmetric confluent white matter changes
    • Lacunar infarcts in basal ganglia/thalamus
    • Cerebral microbleeds (visible on SWI/GRE)
  3. Proceed to genetic testing for NOTCH3 mutations when imaging and clinical features are suggestive 12, 6. This is now the gold standard for diagnosis.

  4. Reserve skin biopsy for cases where genetic testing is inconclusive but clinical suspicion remains high—looking for granular osmiophilic material in vessel walls 4, 7

Prognostic Implications

The severity of temporopolar white matter hyperintensities independently predicts greater disability (modified Rankin Scale >3) and correlates with total white matter volume, Fazekas scores, and number of lacunes in a dose-dependent manner 2. Mean age at death is 64.5 years, with disease duration ranging 10-40 years 5.

Bottom line: In any middle-aged adult (particularly under 60) presenting with white matter changes on MRI, actively look for anterior temporal pole and external capsule involvement. When present alongside recurrent subcortical events, migraine with aura, mood changes, or positive family history, CADASIL should move to the top of your differential and prompt genetic testing 1, 3, 2.

References

Guideline

acr appropriateness criteria® dementia: 2024 update.

Journal of the American College of Radiology, 2025

Research

CADASIL.

Journal of geriatric psychiatry and neurology, 2010

Research

A Young Adult with White Matter Changes and Recurrent Stroke Symptoms.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2022

Research

CADASIL: a practical review for the neurologist.

Practical neurology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.